T. Z. Aliev, T. I. Potemkina, T. Belysheva, T. Valiev, K. Sergeenko, I. A. Kostareva, L. Kudaeva, E. Machneva, T. Ushakova, V. Polyakov, K. Kirgizov, S. Varfolomeeva
{"title":"Dermatologic toxicity of high doses of tiothepa in children. Case report","authors":"T. Z. Aliev, T. I. Potemkina, T. Belysheva, T. Valiev, K. Sergeenko, I. A. Kostareva, L. Kudaeva, E. Machneva, T. Ushakova, V. Polyakov, K. Kirgizov, S. Varfolomeeva","doi":"10.15690/pf.v20i2.2543","DOIUrl":null,"url":null,"abstract":"Hematopoietic stem cell transplantation (HSCT) is a treatment modality for a number of severe malignant and non-neoplastic diseases. Autologous hematopoietic stem cell transplantation (auto-HSCT) improves outcomes in patients with solid and hematological malignancies. Skin lesions at the auto-HSCT stage are quite common and represent an important diagnostic and therapeutic problem. The most significant causes of skin lesions in auto-HSCT are drug toxicity, infectious and viral lesions. Each of the complications can manifest itself to varying degrees as well as combine with others, having a significant negative on the patient’s condition, posing a threat to the patient’s life in severe cases.","PeriodicalId":19997,"journal":{"name":"Pediatric pharmacology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15690/pf.v20i2.2543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Hematopoietic stem cell transplantation (HSCT) is a treatment modality for a number of severe malignant and non-neoplastic diseases. Autologous hematopoietic stem cell transplantation (auto-HSCT) improves outcomes in patients with solid and hematological malignancies. Skin lesions at the auto-HSCT stage are quite common and represent an important diagnostic and therapeutic problem. The most significant causes of skin lesions in auto-HSCT are drug toxicity, infectious and viral lesions. Each of the complications can manifest itself to varying degrees as well as combine with others, having a significant negative on the patient’s condition, posing a threat to the patient’s life in severe cases.